EIF3B Antibody (Center) Blocking Peptide

Produktübersicht

• Artikelname: EIF3B Antibody (Center) Blocking Peptide
• Artikelnummer: ABT-BP9291C
• Hersteller Artikelnummer: BP9291c
• Alternativnummer: ABT-BP9291C-500UG
• Hersteller: Abcepta
• Kategorie: Proteine/Peptide
• Alternative Synonym: Eukaryotic translation initiation factor 3 subunit B {ECO:0000255|HAMAP-Rule:MF_03001}, eIF3b {ECO:0000255|HAMAP-Rule:MF_03001}, Eukaryotic translation initiation factor 3 subunit 9 {ECO:0000255|HAMAP-Rule:MF_03001}, Prt1 homolog, hPrt1, eIF-3-eta {ECO:0000255|HAMAP-Rule:MF_03001}, eIF3 p110 {ECO:0000255|HAMAP-Rule:MF_03001}, eIF3 p116, EIF3B {ECO:0000255|HAMAP-Rule:MF_03001}

Produktbeschreibung

eIF3B binds to the 40S ribosome and promotes the binding of methionyl-tRNAi and mRNA. The eIF3 complex is composed of at least 12 different subunits.

Produkteigenschaften

• NCBI: 8662
• UniProt: P55884
• Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP9291c was selected from the Center region of human EIF3B. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.